Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -135.85% is 356% below its 5-year average of -29.82%, near the low end of its 5-year range (-135.85%–-12.23%).
As of the fiscal period ended Tuesday, June 30, 2026. 87.28% below its 12-month average of -72.54%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -135.85%.
RETURN ON INVESTED CAPITAL (ROIC)
-135.85%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-72.54%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-25.39%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-29.82%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-32.66%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-87.28%
CURRENT VS 3Y AVG
-435.00%
CURRENT VS 5Y AVG
-355.61%
CURRENT VS 10Y AVG
-316.00%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
-280.95%
vs the sector median at left
Viking Therapeutics, Inc.
Market Cap
$3.31B
Return on Invested Capital (ROIC)
-135.85%
TTM Avg
-72.54%
3Y Avg
-25.39%
5Y Avg
-29.82%
Market Cap
$3.30B
Return on Invested Capital (ROIC)
-0.93%
TTM Avg
1.17%
3Y Avg
-16.63%
5Y Avg
-13.35%
Market Cap
$3.36B
Return on Invested Capital (ROIC)
-409.85%
TTM Avg
-257.76%
3Y Avg
-257.76%
5Y Avg
-257.76%
Market Cap
$3.38B
Return on Invested Capital (ROIC)
6.25%
TTM Avg
16.80%
3Y Avg
-7.33%
5Y Avg
-16.60%
Market Cap
$3.19B
Return on Invested Capital (ROIC)
-11.15%
TTM Avg
-28.66%
3Y Avg
-37.37%
5Y Avg
-28.82%
Market Cap
$3.44B
Return on Invested Capital (ROIC)
-79.40%
TTM Avg
-65.84%
3Y Avg
-73.62%
5Y Avg
-96.54%
Market Cap
$3.47B
Return on Invested Capital (ROIC)
-28.15%
TTM Avg
-46.92%
3Y Avg
-38.64%
5Y Avg
-44.96%
Market Cap
$3.48B
Return on Invested Capital (ROIC)
-17.68%
TTM Avg
-22.74%
3Y Avg
-21.16%
5Y Avg
-18.86%
Market Cap
$3.12B
Return on Invested Capital (ROIC)
-66.60%
TTM Avg
-119.97%
3Y Avg
-72.56%
5Y Avg
-159.91%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Viking Therapeutics, Inc. (VKTX) | $3.31B | -135.85% | -72.54% | -25.39% | -29.82% |
| CareDx, Inc (CDNA)vs › | $3.30B | -0.93% | 1.17% | -16.63% | -13.35% |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.36B | -409.85% | -257.76% | -257.76% | -257.76% |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.38B | 6.25% | 16.80% | -7.33% | -16.60% |
| Tarsus Pharmaceuticals, Inc. (TARS)vs › | $3.19B | -11.15% | -28.66% | -37.37% | -28.82% |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.44B | -79.40% | -65.84% | -73.62% | -96.54% |
| Celcuity Inc. (CELC)vs › | $3.47B | -28.15% | -46.92% | -38.64% | -44.96% |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.48B | -17.68% | -22.74% | -21.16% | -18.86% |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.12B | -66.60% | -119.97% | -72.56% | -159.91% |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.52B | -1.07% | -9.16% | -22.10% | -20.63% |
ROIC
-135.8%
ROE
-131.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -135.85% |
| 2026-03-31 | -100.02% |
| 2025-12-31 | -61.55% |
| 2025-09-30 | -38.53% |
| 2025-06-30 | -26.74% |
| 2025-03-31 | -20.33% |
| 2024-12-31 | -17.13% |
| 2024-09-30 | -14.68% |
| 2024-06-30 | -13.53% |
| 2024-03-31 | -12.23% |
| 2023-12-31 | -28.86% |
| 2023-09-30 | -24.87% |
| 2023-06-30 | -20.86% |
| 2023-03-31 | -55.19% |
| 2022-12-31 | -48.00% |
| 2022-09-30 | -41.00% |
| 2022-06-30 | -35.88% |
| 2022-03-31 | -31.40% |
| 2021-12-31 | -27.58% |
| 2021-09-30 | -25.54% |
| 2021-06-30 | -22.61% |
| 2021-03-31 | -19.37% |
| 2020-12-31 | -17.46% |
| 2020-09-30 | -15.86% |
| 2020-06-30 | -14.44% |
| 2020-03-31 | -13.71% |
| 2019-12-31 | -11.78% |
| 2019-09-30 | -10.87% |
| 2019-06-30 | -10.66% |
| 2019-03-31 | -9.54% |
| 2018-12-31 | -8.79% |
| 2018-09-30 | -7.80% |
| 2018-06-30 | -14.85% |
| 2018-03-31 | -24.76% |
| 2017-12-31 | -112.74% |
| 2017-09-30 | -339.98% |
| 2017-06-30 | -175.78% |
| 2017-03-31 | -132.10% |
| 2016-12-31 | -122.23% |
| 2016-09-30 | -112.73% |
| 2016-06-30 | -103.69% |
| 2016-03-31 | -136.57% |
| 2015-12-31 | -89.11% |
| 2015-09-30 | -50.85% |
| 2015-06-30 | -24.08% |
| 2013-12-31 | -101.28% |
| 2013-09-30 | -170.60% |
